Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0000950170-24-030233

Options or other derivatives

  • EVP, Strategy & Innovation acquired 65,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
ROBIN SHERRINGTON EVP, Strategy & Innovation 2024-03-11 Grant or award · Stock Option (Right to Buy) +65,000 65,000 D
Loading xslF345X05/ownership.xml…